Navigation Links
Cornerstone Therapeutics to Host Fourth Quarter and Full-Year 2009 Conference Call
Date:2/18/2010

CARY, N.C., Feb. 18 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that it will host a conference call at 8:30 AM ET on Thursday, March 4, 2010, to discuss its financial results for the quarter and year-ended December 31, 2009.  Management will also provide an update on the Company's strategy, operations and product development pipeline.  Cornerstone intends to issue its financial results press release prior to the conference call.

To participate in the live conference call, please dial 888-873-4896 (U.S. callers) or 617-213-8850 (international callers), and provide passcode 43567041.  A live webcast of the call will also be available through the Investor Relations section of the Company's website.  Please allow extra time prior to the webcast to register, download and install any necessary audio software.

The webcast will be archived for 30 days, and a telephone replay of the call will be available for seven days, beginning at 11:30 AM ET on March 4, 2010, by dialing 888-286-8010 (U.S. callers) or 617-801-6888 (international callers), and providing passcode 97628310.

About Cornerstone Therapeutics

Cornerstone Therapeutics Inc. (Nasdaq: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company foc
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference
2. Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
3. Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call
4. Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)
5. Cornerstone Therapeutics Announces Closing of Chiesi Transaction
6. Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Charter Amendments
7. Cornerstone Therapeutics to Present at BioCenturys 2009 Future Leaders in the Biotech Industry Conference
8. Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results
9. Cornerstone Therapeutics to Host Quarter and Year Ended December 31, 2008 Conference Call
10. Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
11. 3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015  UCB, a multinational ... a global leader in designing, transforming, and running ... Award in recognition of their close collaboration in ... UCB,s global business services (GBS) finance organization. ... and clients that work together effectively to embrace ...
(Date:6/30/2015)... June 30, 2015 /PRNewswire/ - Resverlogix Corp. ("Resverlogix") ... shares of Resverlogix have approved the resolutions relating ... Limited of 5,600,000 units at a price of ... unit being comprised of one common share and ... of approximately CAD$15 million; and (ii) the amendment ...
(Date:6/30/2015)... June 30, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... developing therapeutics that address unmet medical needs in ... Elston will present at the Cantor Fitzgerald ... 8, 2015Time: , 4:45 PM EDTLocation: , Le ... archive): , www.juniperpharma.com, under  ,Investor, or  ...
(Date:6/30/2015)... ... June 30, 2015 , ... With its latest ... selectivity to achieve faster flow rates in comparison to nylon or polyethersulfone (PES). ... space to allow easy liquid flow while trapping particulates as small as 0.2 ...
Breaking Biology Technology:UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2
... , , ... , Transcriptor Reverse Transcriptase is a new recombinant,reverse transcriptase ... polymerase activity, unwinding,activity, and, importantly, RNase H activity. , ... , Due to the special recombinant structure of Transcriptor,Reverse ...
... , , , ... Protector RNase Inhibitor Is a new type of ... interfere with the performance of enzymes in an assay - even,when high amounts (e.g., ... RNA samples. , Is fully active over a wide pH range of ...
... , , , ... The FastStart Taq DNA Polymerase , ... FastStart Taq DNA Polymerase, a chemically modified version,of Taq DNA Polymerase for hot start PCR, was ... The most robust enzyme preparation,currently available , , ...
Cached Biology Technology:Increase the Power and Sensitivity for Your cDNA,Synthesis with the New Transcriptor Reverse Transcriptase 2Increase the Power and Sensitivity for Your cDNA,Synthesis with the New Transcriptor Reverse Transcriptase 3Increase the Power and Sensitivity for Your cDNA,Synthesis with the New Transcriptor Reverse Transcriptase 4Protector RNase Inhibitor Enhance the Protection of,RNA against Degradation 2Challenge the Performance of Your Hot-Start PCRs,with FastStart Taq DNA Polymerase and,the Novel FastStart High Fidelity PCR System 2
(Date:6/25/2015)... DALLAS , June 25, 2015 ... report "Fingerprint Sensors Market by Type (Swipe & Area), Technology, ... (Mobile, Government, Healthcare, Commercial Security & Others) & ... published by marketsandmarkets, the said market is expected ... CAGR of 17.1%. Browse 76 ...
(Date:6/24/2015)... 24, 2015 This report provides market analysis ... six years. It contains an analysis of the drivers, ... their impact from the short, medium, and long term ... industry, market, and technology trends that currently, prevail in ... concerned authorities to efficiently manage the increasing marine traffic ...
(Date:6/23/2015)... MINNETONKA, Minn. , June 23, 2015 /PRNewswire/ ... technology company that supports the entire spectrum of ... iMedNet ™ , the company,s ... has been awarded a Silver 2015 Stevie® Award ... the Health Products & Services Website category.  The ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... release is also available in Chinese on ... stem cell scientists have published new research that improves the ... by Dr Hsiao Chang Chan, from the Chinese University of ... Research into differentiation has led to a variety of breakthroughs ...
... that the drug, ivacaftor (VX-770), significantly improves lung function in ... phase III clinical trial study, "A CFTR Potentiator in Patients ... W. Ramsey, MD of Seattle Children,s Research Institute and the ... England Journal of Medicine . Ivacaftor, also known as ...
... Ill. The conventional wisdom that says the 20th ... more than a myth, according to a forthcoming study ... law., Law professor Paul Heald says overall varietal diversity ... apples in the U.S. actually has increased over the ...
Cached Biology News:Reprogramming stem cells to a more basic form results in more effective transplant, study shows 2Study shows new medication effectively treats underlying cause of cystic fibrosis 2Study: Crop diversity myths persist in media 2Study: Crop diversity myths persist in media 3
... is a fully licensed, high throughput, water bath ... up to 24 microplates. This equates to 9,216 ... ,A robotic arm rapidly transfers a basket of ... ramping times that are considerably faster than those ...
... Ribonuclease is a 27kDa periplasmic enzyme from ... RNA to cyclic nucleotide monophosphate (NMP) intermediates. ... these intermediates to 3-NMPs (1). RNase ONE ... RNases that can cleave a phosophodiester bond ...
... to Dideoxycytidine Dideoxycytidine is a cytidine analog ... inhibiting retroviral activity. Immunogen: Chemical ... Specificity: The specificity of the ddC antiserum ... moles of ddC to moles of ddC analog ...
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
Biology Products: